GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: KOOL
Buy $7

Thermogenesis Corp. (NASDAQ: KOOL) rated to Buy with price target $7 by Maxim Group

Thursday,  Apr 24, 2014  12:00 AM ET by Betsy O'Brien Harrison

Maxim Group rated Thermogenesis
Corp. (NASDAQ: KOOL) to Buy with price target $7.

ThermoGenesis Corp. designs, develops and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins or growth factors from a single unit of cord blood or the patient?s own blood in less than one hour. Initially, the Company developed medical devices for ultra rapid freezing and thawing of blood components, which the Company manufactures and distributes to blood banks and hospitals. The Company?s business model is based on the sale of medical devices and the recurring revenues generated from the companion single-use, sterile disposable products. Its products are sold in 34 countries throughout the world. The Company?s end user customers include private and public cord blood banks, surgeons, hospitals and research institutions.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy